• Je něco špatně v tomto záznamu ?

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

T. Uher, EK. Havrdova, P. Benkert, N. Bergsland, J. Krasensky, B. Srpova, M. Dwyer, M. Tyblova, S. Meier, M. Vaneckova, D. Horakova, R. Zivadinov, D. Leppert, T. Kalincik, J. Kuhle

. 2021 ; 27 (13) : 2001-2013. [pub] 20211006

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012018

BACKGROUND The added value of neurofilament light chain levels in serum sNfL to the concept of no evidence of disease activity 3 NEDA 3 has not yet been investigated in detail OBJECTIVE To assess whether combination of sNfL with NEDA 3 status improves identification of patients at higher risk of disease activity during the following year METHODS We analyzed 369 blood samples from 155 ear

Buffalo Neuroimaging Analysis Center Department of Neurology Jacobs School of Medicine and Biomedical Sciences University at Buffalo The State University of New York Buffalo NY USA

Buffalo Neuroimaging Analysis Center Department of Neurology Jacobs School of Medicine and Biomedical Sciences University at Buffalo The State University of New York Buffalo NY USA Center for Biomedical Imaging Clinical and Translational Science Institute University at Buffalo The State University of New York Buffalo NY USA

Buffalo Neuroimaging Analysis Center Department of Neurology Jacobs School of Medicine and Biomedical Sciences University at Buffalo The State University of New York Buffalo NY USA IRCCS Fondazione Don Carlo Gnocchi ONLUS Milan Italy

Clinical Trial Unit Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland

CORe Department of Medicine The University of Melbourne Melbourne VIC Australia

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Katerinska 30 120 00 Prague Czech Republic

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic CORe Department of Medicine The University of Melbourne Melbourne VIC Australia

Department of Radiology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Melbourne MS Centre Department of Neurology The Royal Melbourne Hospital Melbourne VIC Australia

Neurologic Clinic and Policlinic MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel University Hospital Basel University of Basel Basel Switzerland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012018
003      
CZ-PrNML
005      
20240903113156.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/13524585211047977 $2 doi
035    __
$a (PubMed)34612753
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Uher, Tomas $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Katerinska 30, 120 00 Prague, Czech Republic $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic/CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia $1 https://orcid.org/0000000331609022 $7 xx0189534
245    10
$a Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis / $c T. Uher, EK. Havrdova, P. Benkert, N. Bergsland, J. Krasensky, B. Srpova, M. Dwyer, M. Tyblova, S. Meier, M. Vaneckova, D. Horakova, R. Zivadinov, D. Leppert, T. Kalincik, J. Kuhle
520    9_
$a BACKGROUND: The added value of neurofilament light chain levels in serum (sNfL) to the concept of no evidence of disease activity-3 (NEDA-3) has not yet been investigated in detail. OBJECTIVE: To assess whether combination of sNfL with NEDA-3 status improves identification of patients at higher risk of disease activity during the following year. METHODS: We analyzed 369 blood samples fro $a BACKGROUND: The added value of neurofilament light chain levels in serum (sNfL) to the concept of no evidence of disease activity-3 (NEDA-3) has not yet been investigated in detail. OBJECTIVE: To assess whether combination of sNfL with NEDA-3 status improves identification of patients at higher risk of disease activity during the following year. METHODS: We analyzed 369 blood samples from 155 early relapsing-remitting MS patients on interferon beta-1a. We compared disease activity, including the rate of brain volume loss in subgroups defined by NEDA-3 status and high or low sNfL (> 90th or < 90th percentile). RESULTS: In patients with disease activity (EDA-3), those with higher sNFL had higher odds of EDA-3 in the following year than those with low sNFL (86.5% vs 57.9%; OR = 4.25, 95% CI: [2.02, 8.95]; p = 0.0001) and greater whole brain volume loss during the following year (β = -0.36%; 95% CI = [-0.60, -0.13]; p = 0.002). Accordingly, NEDA-3 patients with high sNfL showed numerically higher disease activity (EDA-3) in the following year compared with those with low sNfL (57.1% vs 31.1%). CONCLUSION: sNfL improves the ability to identify patients at higher risk of future disease activity, beyond their NEDA-3 status. Measurement of sNfL may assist clinicians in decision-making by providing more sensitive prognostic information. $a BACKGROUND The added value of neurofilament light chain levels in serum sNfL to the concept of no evidence of disease activity 3 NEDA 3 has not yet been investigated in detail OBJECTIVE To assess whether combination of sNfL with NEDA 3 status improves identification of patients at higher risk of disease activity during the following year METHODS We analyzed 369 blood samples from 155 ear
650    _2
$a mozek $x diagnostické zobrazování $7 D001921
650    _2
$a lidé $7 D006801
650    _2
$a intermediární filamenta $7 D007382
650    12
$a roztroušená skleróza $x farmakoterapie $7 D009103
650    _2
$a neurofilamentové proteiny $7 D016900
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Havrdova, Eva Kubala $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Benkert, Pascal $u Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland $1 https://orcid.org/0000000165258174
700    1_
$a Bergsland, Niels $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/IRCCS, Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy $1 https://orcid.org/0000000277920433
700    1_
$a Krasensky, Jan $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Srpová, Barbora $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $7 xx0321726
700    1_
$a Dwyer, Michael $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA
700    1_
$a Tyblova, Michaela $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Meier, Stephanie $u Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland
700    1_
$a Vaneckova, Manuela $u Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Horakova, Dana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Zivadinov, Robert $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/Center for Biomedical Imaging, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, USA $1 https://orcid.org/0000000277991485
700    1_
$a Leppert, David $u Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland
700    1_
$a Kalincik, Tomas $u CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Melbourne MS Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia $1 https://orcid.org/0000000337781376 $7 xx0121848
700    1_
$a Kuhle, Jens $u Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland
773    0_
$w MED00006389 $t Multiple sclerosis $x 1477-0970 $g Roč. 27, č. 13 (2021), s. 2001-2013
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34612753 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20240903113153 $b ABA008
999    __
$a ok $b bmc $g 1789558 $s 1163219
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c 13 $d 2001-2013 $e 20211006 $i 1477-0970 $m Multiple sclerosis $n Mult Scler $x MED00006389
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace